How many insider declarations has Kaplan Andrew T. filed?

Kaplan Andrew T. has filed 3 public insider declarations with SEC (Form 4).

What is Kaplan Andrew T.'s role?

Kaplan Andrew T.'s reported role is not specified by the regulator across the filings.

Which companies does Kaplan Andrew T. report trades for?

Kaplan Andrew T. reports trades for 2 companies, including Surgery Partners, Inc..

What is Kaplan Andrew T.'s declared buy vs sell volume?

Across the available history, declared buys total 114.0M€ and disposals 239.6M€.

← Executives ★ Sign in to follow

KA

Kaplan Andrew T.

·SEC (Form 4)

Surgery Partners, Inc.Kailera Therapeutics, Inc.

0

Total declarations

0

Companies

€114m

▲ Purchases (1 ops.)

€240m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

T+90 hit rate

0%

T+90 mean return

-29.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the complete record of transactions filed by Kaplan Andrew T.. Insider active across 2 companies, notably Surgery Partners, Inc.. Cumulatively, 3 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €353.6m. History available since 19 December 2023. The latest transaction was filed on 20 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Kaplan Andrew T.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Surgery Partners, Inc. (US)Kailera Therapeutics, Inc. (US)

Declarations3 total

▲

Kaplan Andrew T.

DirectorExecutives20 Apr 2026Kailera Therapeutics, Inc.

$134M41SEC ↗

8,398,438 shares@ US$16.00100.0% of flowCommon StockSEC:0001193125-26-164388:1

Canonical exit: 19 Jul 2026 (T+90)

●

Kaplan Andrew T.

DirectorExecutives20 Apr 2026Kailera Therapeutics, Inc.

0SEC ↗

17,857,143 sharesCommon StockSEC:0001193125-26-164388:0

▼

Kaplan Andrew T.

DirectorExecutives19 Dec 2023Surgery Partners, Inc.

$262M37SEC ↗

7,826,870 shares@ US$33.44100.0% of flowCommon StockSEC:0000950170-23-072382:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

KA

Kaplan Andrew T.

·SEC (Form 4)

Surgery Partners, Inc.Kailera Therapeutics, Inc.

0

Total declarations

0

Companies

€114m

▲ Purchases (1 ops.)

€240m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

T+90 hit rate

0%

T+90 mean return

-29.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the complete record of transactions filed by Kaplan Andrew T.. Insider active across 2 companies, notably Surgery Partners, Inc.. Cumulatively, 3 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €353.6m. History available since 19 December 2023. The latest transaction was filed on 20 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.